GovChime
Notice ID: 90b6e4455c0040dcb1f0c93c19e56ae5Solicitation

Lisdexamfetamine Dimesylate Capsules Solicitation

Responses closed . Full description on SAM.gov.

Overview

Response deadline
3:00 PM EDT
Posted
July 14, 2026
Notice type
Solicitation
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of WarDEFENSE LOGISTICS AGENCY

Notice details

Office
TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
SPE2D2-26-R-0004
Notice ID
90b6e4455c0040dcb1f0c93c19e56ae5

Description

Amendment 0002 has been issued to extend the solicitation to have offers due on 7/28/2026.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (3)

  • SF30_SPE2D226R00040002.PDF

    18 KBAdded in Solicitation version 6Posted
    Download
  • SF30_SPE2D226R00040001.PDF

    18 KBAdded in Solicitation version 5Posted
    Download
  • SPE2D2-26-R-0004 - Lisdexamfetamine Solicitation.pdf

    1.0 MBAdded in Solicitation version 4Posted
    Download

Lifecycle

  1. 3
    Version 3PresolicitationArchived

    Lisdexamfetamine Dimesylate Capsules

    Notice 1188041e8e314bf68c89113ed0ed4357 on SAM.gov

  2. 4
    Version 4Solicitation

    Type changed from Presolicitation to Solicitation

    Lisdexamfetamine Dimesylate Capsules Solicitation

    Notice 9eb126df9ad34d4ba6ff4edb89302cb6 on SAM.gov

  3. 5
    Version 5Solicitation

    Lisdexamfetamine Dimesylate Capsules Solicitation

    Notice e2e2d8751146426eaaea8538901351f5 on SAM.gov

  4. 6
    Version 6SolicitationCurrent

    Lisdexamfetamine Dimesylate Capsules Solicitation

    Notice 90b6e4455c0040dcb1f0c93c19e56ae5 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

SPE2D2-26-R-0004

Archive Date

Dec 31, 2031

Office Address

PHILADELPHIA, PA, 19111